INCYTE DL-,001 | 64.94 / +1.18% |
Date/Time | 03/29 / 22:58 |
Chg. / Chg.(%) | 0.76 / +1.18% |
Bid | 64.94 |
Ask | 66.26 |
Open | 64.22 |
Previous Close | 64.18 |
High | 65.63 |
Low | 64.22 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 13663 |
ISIN | US45337C1027 |
Security | ICY |
Exchange | Lang & Schwarz |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 71.1400 | ![]() |
953,620 |
IEX | 71.14 | ![]() |
36,772 |
Cboe US | 71.14 | ![]() |
27,894 |
Frankfurt | 64.9100 | ![]() |
200 |
TradeGate | 65.550 | ![]() |
50 |
Hannover | 65.15 | ![]() |
0 |
München | 65.49 | ![]() |
0 |
Düsseldorf | 65.14 | ![]() |
0 |
Berlin | 65.43 | ![]() |
0 |
Stuttgart | 64.960 | ![]() |
0 |
Lang & Schwa.. | 64.94 | ![]() |
|
Quotrix | 65.2300 | ![]() |
|
gettex | 65.430 | ![]() |
|
London Domes.. | 72.26 | 3,019 |
News
- Wall Street back to losses, Dow slides 200 points
02/07/2023 / 19:53 - TeleTrader - US markets lower amid economic data, Fed's Powell
02/07/2023 / 15:30 - TeleTrader - RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire
Personal area
Click on
to activate push quotes.
